Status:

UNKNOWN

The Covid-19 Outpatient Symptom Montelukast Oximetry Trial

Lead Sponsor:

McGill University

Collaborating Sponsors:

Segal Cancer Centre

The McGill Practice Based Research Network

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

Primary care physicians face limited availability of therapeutic options for the treatment of COVID-19 in the outpatient setting. Furthermore, monoclonal antibodies and antiviral therapies that are cu...

Detailed Description

Objectives: Our overarching objective is to determine the efficacy of oral montelukast versus placebo in reducing the duration and severity of COVID-19 symptoms among newly infected at-risk adults in ...

Eligibility Criteria

Inclusion

  • Confirmed SARS-CoV-2 infection, defined as RT-PCR provincial laboratory confirmation;
  • Time from patient reported first symptoms date of enrollment \<7 days;
  • Must be experiencing at least 1 COVID-19 symptom that is either continuing or increasing in severity
  • Severe disease risk factor requirements: i) Age 18-49: ≥3 risk factors ; ii) Age 50-59: ≥2 risk factors; iii) Age 60-69: ≥1 risk factor; iv) Pregnant or Age 70+: No requirements
  • Participants must agree to: i) Use assigned medication for a maximum of 60 days or until relief of symptoms; and ii) Complete the FLU-PRO PLUS and SpO2 daily diary and other study assessments during the course of follow-up.

Exclusion

  • Any hospitalization for COVID-19 symptoms or complications prior to randomization;
  • Use of montelukast ≤ 30 days to screening;
  • Any contraindication to montelukast; and
  • Any condition (including the inability to swallow pills) which, in the opinion of the Principal Investigator, would prevent full participation in and compliance with the trial protocol, or would interfere with the evaluation of trial endpoints.

Key Trial Info

Start Date :

November 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2025

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT04389411

Start Date

November 1 2022

End Date

February 1 2025

Last Update

July 25 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.